Log in to save to my catalogue

P-2258. Characterizing real world infection risk in multiple myeloma patients receiving teclistamab

P-2258. Characterizing real world infection risk in multiple myeloma patients receiving teclistamab

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11779374

P-2258. Characterizing real world infection risk in multiple myeloma patients receiving teclistamab

About this item

Full title

P-2258. Characterizing real world infection risk in multiple myeloma patients receiving teclistamab

Publisher

US: Oxford University Press

Journal title

Open forum infectious diseases, 2025-01, Vol.12 (Supplement_1)

Language

English

Formats

Publication information

Publisher

US: Oxford University Press

Subjects

Subjects and topics

More information

Alternative Titles

Full title

P-2258. Characterizing real world infection risk in multiple myeloma patients receiving teclistamab

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11779374

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11779374

Other Identifiers

ISSN

2328-8957

E-ISSN

2328-8957

DOI

10.1093/ofid/ofae631.2411

How to access this item